ArticleBMJ open2022

Protocol for an open-label, single-arm, multicentre clinical study to evaluate the efficacy and safety of rituximab in the first episode of paediatric idiopathic nephrotic syndrome.

Jialu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.